Order Article Reprints

Muilwijk D, Bierlaagh M, van Mourik P, Kraaijkamp J, van der Meer R, van den Bor R, Heijerman H, Eijkemans R, Beekman J, van der Ent K. Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators. Journal of Personalized Medicine. 2021; 11(12):1376. https://doi.org/10.3390/jpm11121376

Muilwijk, Danya, Marlou Bierlaagh, Peter van Mourik, Jasmijn Kraaijkamp, Renske van der Meer, Rutger van den Bor, Harry Heijerman, René Eijkemans, Jeffrey Beekman, and Kors van der Ent. 2021. "Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators" Journal of Personalized Medicine 11, no. 12: 1376. https://doi.org/10.3390/jpm11121376

Muilwijk, D., Bierlaagh, M., van Mourik, P., Kraaijkamp, J., van der Meer, R., van den Bor, R., Heijerman, H., Eijkemans, R., Beekman, J., & van der Ent, K. (2021). Prediction of Real-World Long-Term Outcomes of People with CF Homozygous for the F508del Mutation Treated with CFTR Modulators. Journal of Personalized Medicine, 11(12), 1376. https://doi.org/10.3390/jpm11121376